Substituted 2,4-pyrimidinediamine compound

PK141438AUndetermined Publication Date: 2012-07-25NOVARTIS AG
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
NOVARTIS AG
Publication Date
2012-07-25
Patent Text Reader

Abstract

A compound of formula I wherein R0, R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 have meanings as defined in the specification, to processes for its production, and to pharmaceutical composition comprising it for the treatment of neoplastic diseases and immune system disorders.
Need to check novelty before this filing date? Find Prior Art